In recognition of AML World Awareness Day, Servier Canada is highlighting the progress made in precision medicine for Acute Myeloid Leukemia (AML).

Alana Matthews thought she had flu she couldn't shake but when she found herself struggling to breathe she received the ...

On Tuesday 21 April 2026, PwC Luxembourg published its EMEA AML Survey 2026, showing that financial institutions... }} ...

"She FaceTimed us while we were walking, even then, she was the one lifting us up." Alana passed away in October 2025, ...

First public disclosure of the chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16-dependent Targeted Glue™ ...

In practical terms, ongoing AML support is about keeping the framework alive. Not rewriting it for the sake of rewriting it, ...

President Nikos Chritodoulides announced before Tuesday’s council of ministers meeting that he had asked the US government ...

Anticipated updates on the company’s leukemia drug SLS009 did not land, dampening near-term catalyst momentum. ・Earlier studies showed SLS009 triggered leukemia cell death and remained active in ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that an abstract highlighting data on its lead drug candidate, annamycin, has been accepted for poster ...

I’d use a dual strategy of income and growth if I had $10,000 to put to work in a TFSA right now. The post How I’d Put $10,000 to Work in a TFSA Right Now appeared first on The Motley Fool Canada.